Peter Barton Hutt, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 3,539 shares at $10.31 ($36K) on 2019-08-08, disclosed to the SEC on 2019-08-12.
Open-market sale of $36k CNCE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MRNA | SELL | 2019-09-18 | $1.8M | — | Filing → |
| CNCE | SELL | 2016-11-21 | $434K | — | Filing → |
| MNTA | SELL | 2014-09-15 | $42K | — | Filing → |